Jeremy Grantham acquired 1.64 Million Abbott Laboratories shares worth $161 Million. That's 0.83% of their equity portfolio (28th largest holding). The first Abbott Laboratories trade was made in Q1 2013. Since then Jeremy Grantham bought shares fifteen more times and sold shares on 26 occasions. The stake costed the investor $62.5 Million, netting the investor a gain of 157% so far.